Literature DB >> 18095876

Adjuvant aromatase inhibitors and emerging quality-of-life considerations.

Susanne Briest, Vered Stearns.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18095876     DOI： 10.1586/14737140.8.1.1

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  2 in total

1.  Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.

Authors:  Keya De Mukhopadhyay; Zhao Liu; Abhik Bandyopadhyay; Nameer B Kirma; Rajeshwar R Tekmal; Shui Wang; Lu-Zhe Sun
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

2.  Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement.

Authors:  Pin Gao; Lili You; Di Wu; Aiping Shi; Qing Miao; Ujala Rana; Dustin Paul Martin; Ye Du; Gang Zhao; Bing Han; Chao Zheng; Zhimin Fan
Journal:  Patient Prefer Adherence       Date:  2018-05-22       Impact factor: 2.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.